Olivier E Pardo (O E Pardo)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Tyrosine Kinase

Cell Proliferation

Endoplasmic Reticulum Stress

Top Venues

International journal of molecular sciences

Cell death discovery

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Sonia Shinhmar, Judith Schaf, Katie Lloyd Jones, Olivier E Pardo, Philip Beesley, Robin Simon Brooke Williams
Developing a Tanshinone IIA Memetic by Targeting MIOS to Regulate mTORC1 and Autophagy in Glioblastoma. International journal of molecular sciences 25 (12) (2024)
Milo Roucairol, Alexios Georgiou, Tristan Cazenave, Filippo Prischi, Olivier E Pardo
DrugSynthMC: An Atom-Based Generation of Drug-like Molecules with Monte Carlo Search. Journal of chemical information and modeling (2024)
Sonia Shinhmar, Judith Schaf, Katie Lloyd Jones, Olivier E Pardo, Philip Beesley, Robin Simon Brooke Williams
Developing a Tanshinone IIA Memetic by Targeting MIOS to Regulate mTORC1 and Autophagy in Glioblastoma. International journal of molecular sciences 25 (12) (2024)
Sonia Shinhmar, Judith Schaf, Katie Lloyd Jones, Olivier E Pardo, Philip Beesley, Robin Simon Brooke Williams
Developing a Tanshinone IIA Memetic by Targeting MIOS to Regulate mTORC1 and Autophagy in Glioblastoma. International journal of molecular sciences 25 (12) (2024)
Oksana Malanchuk, Anna Bdzhola, Sergii Palchevskyi, Volodymyr G Bdzhola, Peng Chai, Olivier E Pardo, Michael J Seckl, Adrija Banerjee, Sew Peak Chew, Mark Skehel, Lalitha Guruprasad, Alexander Zhyvoloup, Ivan Gout, Valeriy Filonenko
Investigating the Regulation of Ribosomal Protein S6 Kinase 1 by CoAlation. International journal of molecular sciences 25 (16) (2024)
Oksana Malanchuk, Anna Bdzhola, Sergii Palchevskyi, Volodymyr G Bdzhola, Peng Chai, Olivier E Pardo, Michael J Seckl, Adrija Banerjee, Sew Peak Chew, Mark Skehel, Lalitha Guruprasad, Alexander Zhyvoloup, Ivan Gout, Valeriy Filonenko
Investigating the Regulation of Ribosomal Protein S6 Kinase 1 by CoAlation. International journal of molecular sciences 25 (16) (2024)
Yakinthi Chrisochoidou, Rajat Roy, Pooyeh Farahmand, Guadalupe Gonzalez, Jennifer Doig, Lukas Krasny, Ella F Rimmer, Anne E Willis, Marion MacFarlane, Paul H Huang, Neil O Carragher, Alison F Munro, Daniel J Murphy, Kirill Veselkov, Michael J Seckl, Miriam F Moffatt, William O C Cookson, Olivier E Pardo
Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. Cell death & disease 14 (11) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
Judith Schaf, Sonia Shinhmar, Qingyu Zeng, Olivier E Pardo, Philip Beesley, Nelofer Syed, Robin Simon Brooke Williams
Enhanced Sestrin expression through Tanshinone 2A treatment improves PI3K-dependent inhibition of glioma growth. Cell death discovery 9 (1) (2023)
Judith Schaf, Sonia Shinhmar, Qingyu Zeng, Olivier E Pardo, Philip Beesley, Nelofer Syed, Robin Simon Brooke Williams
Enhanced Sestrin expression through Tanshinone 2A treatment improves PI3K-dependent inhibition of glioma growth. Cell death discovery 9 (1) (2023)
Judith Schaf, Sonia Shinhmar, Qingyu Zeng, Olivier E Pardo, Philip Beesley, Nelofer Syed, Robin Simon Brooke Williams
Enhanced Sestrin expression through Tanshinone 2A treatment improves PI3K-dependent inhibition of glioma growth. Cell death discovery 9 (1) (2023)
Judith Schaf, Sonia Shinhmar, Qingyu Zeng, Olivier E Pardo, Philip Beesley, Nelofer Syed, Robin Simon Brooke Williams
Enhanced Sestrin expression through Tanshinone 2A treatment improves PI3K-dependent inhibition of glioma growth. Cell death discovery 9 (1) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, Michael J Seckl
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 13 (1) (2022)
Marina Georgiou, Panagiota Ntavelou, William Stokes, Rajat Roy, Geoffrey J Maher, Tsvetana Stoilova, Josephine A M Y Choo, Callum P Rakhit, Miguel Martins, Paul Ajuh, Neil Horowitz, Ross S Berkowitz, Kevin Elias, Michael J Seckl, Olivier E Pardo
ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma. Oncogene 41 (18) (2022)
Stelios Chrysostomou, Rajat Roy, Filippo Prischi, Lucksamon Thamlikitkul, Kathryn L Chapman, Uwais Mufti, Robert L Peach, Laifeng Ding, David C Hancock, Christopher Moore, Miriam Molina-Arcas, Francesco Mauri, David James Pinato, Joel M Abrahams, Silvia Ottaviani, Castellano L, Georgios Giamas, Jennifer Pascoe, Devmini Moonamale, Sarah J Pirrie, Claire Gaunt, Lucinda Billingham, Neil M Steven, Michael Cullen, David Hrouda, Mathias Winkler, John Post, Philip Cohen, Seth J Salpeter, Vered Bar, Adi Zundelevich, Shay Golan, Dan Leibovici, Romain Lara, David R Klug, Sophia N Yaliraki, Mauricio Barahona, Yulan Wang, Julian Downward, J Mark Skehel, Maruf M U Ali, Michael J Seckl, Olivier E Pardo
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer. Science translational medicine 13 (602) (2021)